Skip to main content
Valneva SE logo

Valneva SE — Investor Relations & Filings

Ticker · VLA ISIN · FR0004056851 LEI · 969500DIVIP5VKNW4948 PA Manufacturing
Open in API
Filings indexed 1,662 across all filing types
Latest filing 2024-09-13 Capital/Financing Update
Country FR France
Listing PA VLA

About Valneva SE

https://valneva.com/

Valneva SE is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet medical needs. The company has leveraged its expertise to commercialize three vaccines, including a single-shot vaccine for chikungunya. Its research and development pipeline features a broad range of vaccine candidates, including those targeting Lyme disease, Shigella, and Zika.

Recent filings

Filing Released Lang Actions
Valneva annonce le succès de son augmentation de capital et lève environ 60 millions d’euros
Capital/Financing Update Classification · 99% confidence The document is a press release dated September 13, 2024, titled "Valneva annonce le succès de son augmentation de capital et lève environ 60 millions d'euros" (Valneva announces the success of its capital increase and raises approximately 60 million euros). The text details the terms, use of proceeds, and resulting dilution from a recent share issuance. This content directly relates to fundraising, financing activities, and capital structure changes. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is substantial (22,813 chars), indicating it is the primary announcement, not just a brief notice of publication (RPA/RNS).
2024-09-13 French
Valneva Announces the Launch of a Private Placement of Ordinary Shares for Approximately 60 Million Euros
Capital/Financing Update Classification · 99% confidence The document is a press release dated September 12, 2024, titled "Valneva Announces the Launch of a Private Placement of Ordinary Shares for Approximately 60 Million Euros." The text explicitly details the intention to issue new ordinary shares via a private placement through an accelerated bookbuilding process, specifying the price, the intended use of proceeds (funding clinical programs), and the legal exemptions relied upon (Regulation S, Rule 144A). This activity directly relates to fundraising, financing activities, and changes in the capital structure. Therefore, it fits the definition of 'Capital/Financing Update' (CAP). It is not a full annual report (10-K), an earnings release (ER), or a general regulatory announcement (RNS), as it concerns a specific financing event.
2024-09-12 English
Valneva annonce le lancement d’un projet d’augmentation de capital d’environ 60 millions d’euros
Capital/Financing Update Classification · 99% confidence The document is a press release dated September 12, 2024, announcing Valneva SE's intention to launch a capital increase ('Augmentation de Capital') of approximately 60 million euros through the issuance of new ordinary shares via an accelerated book-building process. The text explicitly details the purpose of the funds (financing clinical programs, commercialization, R&D) and the mechanics of the share issuance, including pricing, exemptions from prospectus requirements (Regulation S, Rule 144A), and lock-up agreements. This content directly relates to fundraising, financing activities, and capital structure changes, fitting the definition of 'Capital/Financing Update'. It is not a full annual report (10-K), an earnings release (ER), or a simple announcement of a report (RPA).
2024-09-12 French
VALNEVA - Declaration of shares and voting rights: August 31, 2024
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Declaration of shares and voting rights August 31, 2024'. It details the total number of shares, total voting rights (including and excluding suspended rights), and notes specific dates related to voting rights changes. This content directly relates to the official declaration of voting rights and share capital structure, which aligns perfectly with the definition for 'Declaration of Voting Results & Voting Rights Announcements' (DVA). Although it is a declaration, it is not a result of a vote (like AGM results), but a statement of the underlying voting power, making DVA the most precise fit among the provided options.
2024-09-04 English
VALNEVA - Déclaration d’actions et de droits de vote : 31 août 2024
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled "Déclaration d'actions et de droits de vote" (Declaration of shares and voting rights) and is dated August 31, 2024, declared on September 4, 2024. It explicitly details the total number of shares, the total number of voting rights (gross and net), and notes variations related to double voting rights ('droit de vote double'). This content directly corresponds to the official reporting of voting rights and share capital structure changes, which aligns perfectly with the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA). It is not an AGM presentation (AGM-R), a general earnings release (ER), or a full annual report (10-K).
2024-09-04 French
FORM 6-K
Regulatory Filings
2024-09-03 English

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.